secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001213900-25-056911
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies (OSTX) raises up to $8M via warrant exercise inducement; extends cash runway into H2 2026
--------------------------------------------------------------------------------

- Holders exercise 1.57M old warrants ($1.12) for cash; receive new 5-year warrants at $3.00/sh.
- Gross proceeds up to ~$8M; $1.76M already received, extending cash runway into H2 2026.
- Proceeds to support regulatory/pre-commercial efforts for OST-HER2 in osteosarcoma.
- Offering period June 20 to July 10, 2025; solicitation agent fee 5% of gross proceeds.
- Company reiterates BLA submission to FDA in Q3 2025; potential PRV sale (most recent at $160M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025056911/0001213900-25-056911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025056911/ea0246590-8k_ostherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-056911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer